Palbociclib CAS:571190-30-2

Palbociclib  CAS:571190-30-2
Product Details

Product Information

CAS NO.571190-30-2 3.png
Product NamePalbociclib
Molecular Weight447.54
Spec / Purity98%min
Supply Capacity
DetailsPalbociclib (PD-0332991) is a drug for the treatment of ER-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. The drug received an accelerated approval from the FDA on February 3, 2015, as a treatment (in combination with letrozole) for patients with estrogen receptor-positive advanced breast cancer.

If you are going to consult the information about palbociclib cas:571190-30-2 from one of the leading Bioactive Molecules manufacturers and suppliers in China, It is always at your service.